Back
AbbVie Vs. Guardant Health Industry Stock Comparison
Buy
70
ABBV
AbbVie
Last Price:
$202.13
Seasonality Move:
3.69%
Sell
19
GH
Guardant Health
Last Price:
$42.91
Seasonality Move:
1.62%
Sell
19
Guardant Health (GH)
is a Sell
Is Guardant Health a Buy, Sell or Hold?
-
The current Guardant Health [GH] share price is $42.91. The Score for GH is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
GH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
ABBV Stock Price Chart
GH Stock Price Chart
What is Guardant Health's stock price today?
-
The Guardant Health share price today is $42.91The current trend is moderately bearish and GH is experiencing selling pressure, which indicates risk of future bearish movement.
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.78 | Buy |
Relative Strength Index (14 RSI): | 77.27 | Buy |
Chaikin Money Flow: | 248436 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (174.59 - 195.65) | Buy |
Bollinger Bands (100): | (173.32 - 194.44) | Buy |
GH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.65 | Buy |
Relative Strength Index (14 RSI): | 45.79 | Sell |
Chaikin Money Flow: | -4508676 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.9 - 49.18) | Sell |
Bollinger Bands (100): | (24.01 - 42.45) | Buy |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 195.96 | Buy |
20-day SMA: | 188.51 | Buy |
50-day SMA: | 180.71 | Buy |
200-day SMA: | 180.85 | Buy |
8-day EMA: | 196.58 | Buy |
20-day EMA: | 190.38 | Buy |
50-day EMA: | 184.74 | Buy |
200-day EMA: | 179.85 | Buy |
GH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.46 | Sell |
20-day SMA: | 46.8 | Sell |
50-day SMA: | 40.06 | Buy |
200-day SMA: | 30.49 | Buy |
8-day EMA: | 46.3 | Sell |
20-day EMA: | 45.43 | Sell |
50-day EMA: | 41.15 | Buy |
200-day EMA: | 32.36 | Buy |
AbbVie Earnings Growth & ABBV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.23 per share, an increase this year of $2.10 per share, and an increase next year of $1.57 per share.
Guardant Health Earnings Growth & GH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.20 per share, and an increase next year of $0.38 per share.
AbbVie Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Guardant Health Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |